The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Elkington And Fife competitive analysis

Loading summary...

Latest oppositions filed by Elkington And Fife

Explore patent oppositions filed by Elkington And Fife against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3756650
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEOct 1, 2025
EP4218732
Tablets Comprising Eltrombopag OlamineNOVARTISSep 9, 2025
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 4, 2025
EP4233846
Pharmaceutical FormulationsGILEAD SCIENCESSep 4, 2025
EP3359572
Method For Treating Multiple SclerosisF HOFFMANN LA ROCHEAug 27, 2025
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 27, 2025
EP3135287
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 20, 2025
EP3324956
Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 ReceptorANAVEX LIFE SCIENCESJun 12, 2025
EP4014976
Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)IDORSIA PHARMACEUTICALSMay 29, 2025
EP3815684
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDMay 9, 2025

Latest PTAB cases involving Elkington And Fife

Discover the latest PTAB cases involving Elkington And Fife, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elkington And Fife with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELKINGTON AND FIFE92 - - -
AMARIN PHARMACEUTICALS IRELAND - 15 - 1
F HOFFMANN LA ROCHE16140 - -
NOVARTIS6422 - 21